General Information
Version
1.0
Revision date
2024-09-04
Product name
Regulation (February 11, 2015)
1.2.1 Relevant identified uses
Cetrorelix acetate for injection is indicated for the inhibition of premature LH surges in women undergoing controlled ovarian stimulation
Manufacturer Name
Gland Pharma Limited
Icons in SDS
Company Information
company name
Fresenius Kabi USA, LLC
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H360
Hazard statements
Code
Statements
H360
May damage fertility or the unborn child
Section 2
SECTION 2: Hazards identification
Classification (GHS-US)
Reproductive toxicity Category 1B H360 Combustible Dust
2.2 Label elements
GHS‐US/CA Labeling
Hazard pictograms
GHS08
Signal word
Danger
Hazard statements
May form combustible dust concentrations in air. H360 ‐ May damage fertility or the unborn child.
Precautionary statements
P201 ‐ Obtain special instructions before use P202 ‐ Do not handle until all safety precautions have been read and understood. P280 ‐ Wear protective gloves, protective clothing, and eye protection. P308+P313 ‐ If exposed or concerned: Get medical advice/attention. P405 ‐ Store locked up. P501 ‐ Dispose of contents/container in accordance with local, regional, national, and international regulations.
Additional information
Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. Proper grounding procedures to avoid static electricity should be followed. Prevent dust accumulation (to minimize explosion hazard). Avoid generating dust.
2.3 Other hazards
Exposure may aggravate pre‐existing eye, skin, or respiratory conditions.
Ingredient(s) with unknown acute toxicity
No additional information available
